title: Clinical impact of FDG PET-CT on the management of patients with locally advanced cervical carcinoma.
abstract: OBJECTIVE
  To evaluate the impact of staging FDG PET-CT on the initial management of patients with locally advanced cervical carcinoma (LACC) and any prognostic variables predicting survival.
  
  
  METHODS
  Retrospective analysis of consecutive patients undergoing FDG PET-CT for staging of LACC in a single tertiary referral centre, between April 2008 and August 2011. Comparison was made between MRI and PET-CT findings and any subsequent impact on treatment intent or radiotherapy planning was evaluated.
  
  
  RESULTS
  Sixty-three patients underwent FDG PET-CT for initial staging of LACC. Major impact on management was found in 20 patients (32%), a minor impact in five (8%), and no impact in 38 (60%). In those patients where PET-CT had a major impact, 12 had more extensive local nodal involvement, five had occult metastatic disease, two had synchronous tumours, and one patient had equivocal lymph nodes on MRI characterized as negative. PET-positive nodal status at diagnosis was found to be a statistically significant predictor of relapse-free survival (p < 0.05).
  
  
  CONCLUSIONS
  Staging FDG PET-CT has a major impact on the initial management of approximately one-third of patients with LACC by altering treatment intent and/or radiotherapy planning. PET-defined nodal status is a poor prognostic indicator.
authors.affiliation: Department of Clinical Radiology, St James's University Hospital, Leeds, UK.
authors.forename: S
authors.initials: S
authors.lastname: Fleming
authors.affiliation: Department of Clinical Oncology, St James's University Hospital, Leeds, UK.
authors.forename: R A
authors.initials: RA
authors.lastname: Cooper
authors.affiliation: Department of Clinical Radiology, St James's University Hospital, Leeds, UK.
authors.forename: S E
authors.initials: SE
authors.lastname: Swift
authors.affiliation: Leeds Cancer Research UK Centre, St James's University Hospital, Leeds, UK.
authors.forename: H H
authors.initials: HH
authors.lastname: Thygesen
authors.affiliation: Department of Clinical Radiology, St James's University Hospital, Leeds, UK; Department of Nuclear Medicine, St James's University Hospital, Leeds, UK.
authors.forename: F U
authors.initials: FU
authors.lastname: Chowdhury
authors.affiliation: Department of Clinical Radiology, St James's University Hospital, Leeds, UK; Department of Nuclear Medicine, St James's University Hospital, Leeds, UK.
authors.forename: A F
authors.initials: AF
authors.lastname: Scarsbrook
authors.affiliation: Department of Clinical Radiology, St James's University Hospital, Leeds, UK; Department of Nuclear Medicine, St James's University Hospital, Leeds, UK. Electronic address: chirag.patel13@nhs.net.
authors.forename: C N
authors.initials: CN
authors.lastname: Patel
mesh_terms: D000328:Adult; D000368:Aged; D002584:Cervix Uteri / Q000000981:diagnostic imaging; D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008875:Middle Aged; D064847:Multimodal Imaging / Q000379:methods*; D009367:Neoplasm Staging; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D055815:Young Adult
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18